You are here

  • Home
  • Archive
  • Volume 84, Issue 11
  • IMPROVEMENT IN QUALITY-OF-LIFE AND DEPRESSIVE SYMPTOMS DURING LONG-TERM TREATMENT WITH ESLICARBAZEPINE ACETATE: BIA-2093-301 STUDY

Article info

Article menu
Download PDFPDF
Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013
093
IMPROVEMENT IN QUALITY-OF-LIFE AND DEPRESSIVE SYMPTOMS DURING LONG-TERM TREATMENT WITH ESLICARBAZEPINE ACETATE: BIA-2093-301 STUDY

Authors

  • Joyce Cramer Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL–Portela & Co, SA, S Mamede do Coronado, Portugal PubMed articlesGoogle scholar articles
  • C Elger Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL–Portela & Co, SA, S Mamede do Coronado, Portugal PubMed articlesGoogle scholar articles
  • P Halasz Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL–Portela & Co, SA, S Mamede do Coronado, Portugal PubMed articlesGoogle scholar articles
  • D Hodoba Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL–Portela & Co, SA, S Mamede do Coronado, Portugal PubMed articlesGoogle scholar articles
  • A Czlonkowska Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL–Portela & Co, SA, S Mamede do Coronado, Portugal PubMed articlesGoogle scholar articles
  • Joana Maia Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL–Portela & Co, SA, S Mamede do Coronado, Portugal PubMed articlesGoogle scholar articles
  • L Almeida Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL–Portela & Co, SA, S Mamede do Coronado, Portugal PubMed articlesGoogle scholar articles
  • P Soares-da-Silva Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL–Portela & Co, SA, S Mamede do Coronado, Portugal PubMed articlesGoogle scholar articles

    Citation

    Cramer J, Elger C, Halasz P, et al
    IMPROVEMENT IN QUALITY-OF-LIFE AND DEPRESSIVE SYMPTOMS DURING LONG-TERM TREATMENT WITH ESLICARBAZEPINE ACETATE: BIA-2093-301 STUDY
    Journal of Neurology, Neurosurgery & Psychiatry 2013;84:e2.

    Publication history

    • First published October 9, 2013.
    Online issue publication 
    April 04, 2017

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions